About Sepsis Scout
Sepsis Scout is a company based in San Francisco (United States) founded in 2017 by Wei-Jien Tan, Robert Quinn, and Wei Jien Tan. Sepsis Scout has raised $4.71 million across 5 funding rounds from investors including HHS, Kapor Capital and Y Combinator. Sepsis Scout operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, Flow Neuroscience and BioIntelliSense, among others.
- Headquarter San Francisco, United States
- Founders Wei-Jien Tan, Robert Quinn, Wei Jien Tan
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.71 M (USD)
in 5 rounds
-
Latest Funding Round
$254.32 K (USD), Grant
Aug 01, 2022
-
Investors
HHS
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Sepsis Scout
Unlock access to complete
Unlock access to complete
Funding Insights of Sepsis Scout
Sepsis Scout has successfully raised a total of $4.71M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $254.32 thousand completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sepsis Scout
Sepsis Scout has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Kapor Capital and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed stage venture capital firm investing in US
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
muru-D is operated as Telstra's hub for digital innovation and incubation.
|
Locked | Locked | Locked |
Investor details for Sepsis Scout
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sepsis Scout
Investment portfolio details for Sepsis Scout
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sepsis Scout
Detailed financials for Sepsis Scout
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sepsis Scout Comparisons
Peer comparison for Sepsis Scout
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sepsis Scout
Sepsis Scout operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, Flow Neuroscience and BioIntelliSense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Panic disorders are treated via breathing device and mobile app.
|
Detailed competitors of Sepsis Scout
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sepsis Scout
Complete news archive for Sepsis Scout
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sepsis Scout
Sepsis Scout was founded in 2017.
Sepsis Scout is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Robert Quinn is the current CEO of Sepsis Scout. They have also founded this company.
Sepsis Scout is a funded company, having raised a total of $4.71M across 5 funding rounds to date.
Sepsis Scout was established in 2017 in San Francisco, United States, within the health technology sector. A wearable system integrated with artificial intelligence is utilized to track vital signs and physiological data. Subtle variations and interactions are identified to enable early sepsis detection and intervention, with a focus on cancer patients. Operations center on predictive monitoring for improved patient outcomes in clinical settings.
Sepsis Scout's top competitors include Endotronix, Oxehealth and BioIntelliSense.
Sepsis Scout has 5 investors. Key investors include HHS, Kapor Capital, Y Combinator, muru-D, and Aligned Partners Venture Services.